Crimson Healthcare, a med-tech company has raised funding of Rs 1.75 crore from Mumbai Angels Network. Crimson healthcare was founded in 2015 and is headquartered in Delhi.
Crimson Healthcare is focused on improving ostomy care. It aims to improve the lives of ostomates globally who defecate in a bag hanging from their abdomen. Crimson has developed an ostomy management device, SphinX which is a soft and pliable insertable port and provides a safe, secure, and discreet solution to stoma management while restoring continence to the patient.
Founded by Pranav Chopra and Neeraj Kumar both alumni of Stanford India Biodesign with an aim to innovate cutting edge solutions for various problems in the healthcare system with advanced engineering and technologies. Crimson is supported by the Indo US Science and Technology Forum and the Department of Biotechnology through its Biotechnology Ignition Grant (BIG).
The technology has been developed under the School of International Biodesign, a Department of Biotechnology, Govt. of India supported collaborative program between All India Institute of Medical Sciences, Indian Institute of Technology-Delhi, and International Partners and licensed to Crimson Healthcare by Biotech Consortium India Limited, New Delhi.